Author

Maria Varela

Benefits and harms of novel therapeutics in HCC
Benefits and harms of novel therapeutics in HCC

Maria Varela

EARLY NIVOLUMAB ADDITION TO REGORAFENIB IN PATIENTS WITH HEPATOCELLULAR CARCINOMA PROGRESSING UNDER 1ST LINE THERAPY (GOING TRIAL). INTERIM ANALYSIS AND SAFETY PROFILE
EARLY NIVOLUMAB ADDITION TO REGORAFENIB IN PATIENTS WITH HEPATOCELLULAR CARCINOMA PROGRESSING UNDER 1ST LINE THERAPY (GOING TRIAL). INTERIM ANALYSIS AND SAFETY PROFILE

Maria Varela  et al.

PREVALENCE AND PATTERN OF ALCOHOL CONSUMPTION IN PATIENTS WITH HEPATOCELLULAR CARCINOMA
PREVALENCE AND PATTERN OF ALCOHOL CONSUMPTION IN PATIENTS WITH HEPATOCELLULAR CARCINOMA

Maria Varela  et al.

IMPACT OF THE COVID-19 PANDEMIC IN THE DIAGNOSIS AND THERAPY OF SINGLE HEPATOCELLULAR CARCINOMA LESS THAN 3 CM IN A WESTERN COUNTRY
IMPACT OF THE COVID-19 PANDEMIC IN THE DIAGNOSIS AND THERAPY OF SINGLE HEPATOCELLULAR CARCINOMA LESS THAN 3 CM IN A WESTERN COUNTRY

Maria Varela  et al.

CHARACTERISTICS AND SURVIVAL OF PATIENTS WITH HEPATOCELLULAR CARCINOMA IN NATURAL HISTORY IN A WESTERN COUNTRY
CHARACTERISTICS AND SURVIVAL OF PATIENTS WITH HEPATOCELLULAR CARCINOMA IN NATURAL HISTORY IN A WESTERN COUNTRY

Maria Varela  et al.

EARLY SARS-COV-2-RELATED MORTALITY OF LIVER CANCER PATIENTS: CANCER STAGE MATTERS
EARLY SARS-COV-2-RELATED MORTALITY OF LIVER CANCER PATIENTS: CANCER STAGE MATTERS

Maria Varela  et al.

Item 1 - 6 / 6
1